期刊文献+

高发区食管癌及癌前病变的血清蛋白质谱分析 被引量:3

Analysis of serum proteomic pattern between patients with esophageal cancer and precancerous lesions in high risk area
原文传递
导出
摘要 目的检测高发区食管癌及癌前病变患者血清蛋白质谱,建立蛋白指纹图谱模型并探究其筛查价值。方法收集38名健康对照者、63例食管鳞状上皮不典型增生患者(I级26例,Ⅱ级26例,Ⅲ级11例)和36例进展期食管癌患者的内镜活检和血清标本,用CMlO蛋白芯片及表面增强激光解析电离飞行时间质谱(SELDI-TOF-MS)技术检测标本的蛋白表达谱。支持向量机算法分别建立食管癌及癌前病变诊断模型,并经留一法交叉验证。结果①区分进展期食管癌和健康对照的诊断模型特异性为89.47%,敏感性为83.33%。②区分进展期食管癌和I、Ⅱ、Ⅲ级不典型增生的诊断模型的特异性分别为92.31%、80.77%、90.91%,敏感性分别为80.56%、83.33%、94.44%。③在上述诊断模型中,质荷比(m/z)峰值在相对分子质量4291、5644、5664、8775处重复出现。结论SELDI-TOF-MS技术和支持向量机算法的应用,为高发区高危人群中食管癌及癌前病变的早期筛查和诊断提供了一条新途径。4291、5644、5664、87754个质荷比峰对食管各级病变有相似的分类作用,可能是与食管癌变过程中相关的生物学标志物。 Objective To evaluate the potential differences in serum proteomic profiles between patients with esophageal squamous cell carcinoma(ESCC) and precancerous lesions in order to establish proteomic pattern model for diagnosis of ESCC and precancerous lesions in high risk area ,and to investigate its value in screening ESCC. Methods The serum and endoscopic biopsy samples were obtained from 38 normal controls, 63 patients with atypical hyperplasia(class I 26 cases, class Ⅱ 26 cases, classⅢ 11 cases) and 36 patients with advanced esophageal carcinoma. The serum proteomic patterns were examined using surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) and CM10 protein chip. The data was analyzed and disease diagnostic models were established using support vector machine(SVM). The diagnostic model was evaluated and validated by leave one cross validation. Results ① The diagnostic model could differentiate advanced esophageal carcinoma from normal controls with a specificity of 89. 47% and a sensitivity of 83. 33%. ② The results delivered 92.31%, 80.77% and 90.91% specificity, and 80.56%, 83.33% and 94.44% sensitivity for discrimination of atypical hyperplasia I , Ⅱ and Ⅲ, respectively, using diagnostic models. ③Four (4291, 5644, 5664, 8775) m/z peaks observed repeatedly using diagnostic models. Conclusions The SELDI-TOF-MS and SVM provide a new approach for discrimination of ESCC and precancerous lesions in high risk area. Four (4291, 5644, 5664, 8775) m/z peaks may considered as potential biomarkers which related to the ESCC and esophageal precancerous lesions.
出处 《中华消化杂志》 CAS CSCD 北大核心 2008年第3期148-152,共5页 Chinese Journal of Digestion
基金 河北省科技攻关基金资助项目(052761361)
关键词 食管肿瘤 蛋白质组学 质谱 基质辅助激光解析电离 Esophageal neoplasms Proteomics Spectrometry, mass, matrix-assisted laser desorption-ionization
  • 相关文献

参考文献2

二级参考文献18

  • 1Serrano M, Harmon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of 3 cyclin D/CDK4 [J]. Nature 1993; 366:704-7. 被引量:1
  • 2Kuwano H, Kato H, Miyazaki T, et al. Genetic alterations in esophageal cancer [J]. Surg Today 2005; 35:7-18. 被引量:1
  • 3Ralhan R, Mathew R, Arora S, et al. Frequent alterations in the expression of tumor suppressor genes pl6INK4A and pRb in esophageal squamous cell carcinoma in the Indian population [J]. J Cancer Res Clin Oncol 2000; 126:655-60. 被引量:1
  • 4Garinis GA, Gorgoulis VG, Mariatos G, et al. Association of allelic loss at the FHIT locus and p53 alterations with tumor kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs) [J]. J Pathol 2001; 193:55-65. 被引量:1
  • 5Ji L, Fang B, Yen N, et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression [J]. Cancer Res 1999; 59: 3333-9. 被引量:1
  • 6Menin C, Santacatterina M, Zambon A, et al. Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancer [J]. Cancer Genet Cytogenet 2000; 119:56-61. 被引量:1
  • 7Mori M, Mimori K, Shiraishi T, et al. Altered expression of FHIT in carcinoma and precarcinomatous lesions of the esophagus[J]. Cancer Res 2000,60:1177-82. 被引量:1
  • 8Li LD, Lu FZ, Zhang SW, et al. To predict and analyze the changing tendency of malignant tumor for twenty years in China [J]. Chill J Oncol (Chin) 1997; 19:3-9. 被引量:1
  • 9Metzger R, Schneider PM, Warnecke-Eberz U, et al. Molecular biology of esophageal cancer [J]. Onkologie 2004; 27:200-6. 被引量:1
  • 10Powell EL, Leoni LM, Canto MI, et al. Concordant loss of MTAP and pl6/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications [J]. Am J Surg Pathol 2005; 29:1497-1504. 被引量:1

共引文献868

同被引文献39

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部